Microdeletions in FMR2 may be a significant cause of premature ovarian failure

Journal of Medical Genetics

Volumn 36, Issue 10, 1999, Pages 767-770

  Murray, Anna ^a   Webb, James ^a   Dennis, Nick ^b   Conway, Gerard ^c   Morton, Newton ^b  

^a SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^b PRINCESS ANNE HOSPITAL   (United Kingdom)

^c MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Deletion; FMR2; Premature ovarian failure

Indexed keywords

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FRAGILE X SYNDROME; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; OVARY DISEASE; PRIORITY JOURNAL; SCREENING TEST; SEQUENCE ANALYSIS; TRINUCLEOTIDE REPEAT;

EID: 0032826352     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.36.10.767     Document Type: Article

References (20)

1. Knight SJL, Flannery AV, Hirst MC, et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 1993;74:127-34.
2. Zhong N, Ju W, Curley D, et al. A survey of FRAXE allele sizes in three populations. Am J Med Genet 1996;64:415-19.
3. Hamel BCJ, Smits APT, Degraaff E, et al. Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet 1994;55:923-31.
4. Mulley JC, Yu S, Loesch DZ, et al. FRAXE and mental retardation. J Med Genet 1995;32:162-9.
5. Barnicoat AJ, Wang Q, Turk J, et al. Clinical, cytogenetic, and molecular analysis of three families with FRAXE. J Med Genet 1997;34:13-18.
6. Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet 1996;13:105-9.
7. Gu Y, Shen Y, Gibbs RA, Nelson DL. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet 1996;13:109-13.
8. Gecz J, Bielby S, Sutherland GR, Mulley JC, Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics 1997;44:201-14.
9. Gedeon AK, Keinanen M, Ades LC, et al. Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. Am J Hum Genet 1995;56:907-14.
10. Macpherson J, Murray A, Jacobs PA. FRAXE microdeletions in two interesting families. 7th International Workshop on Fragile X and X-linked Mental Retardation 1995:abstract 65.
11. Zhong N, Yang W, Houck GE, et al. Identification of FRAXE mutations: a FRAXE microdeletion associated with a complex mosaic FRAXA mutation. 7th International Workshop on Fragile X and X-linked Mental Retardation 1995:abstract 62.
12. Holden JJA, JulienInalsingh C, Chalifoux M, et al. Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities. Am J Med Genet 1996;64:420-4.
13. Brown TC, Tarleton JC, Go RCP, Longshore JW, Descartes M. Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles. Am J Med Genet 1997;73:447-55.
14. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-6.
15. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998;13:1184-8.
16. Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998;35:637-40.
17. Murray A, Youings S, Dennis N, et al. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet 1996;5:727-35.
18. Richards RI, Crawford J, Narahara K, et al. Dynamic mutation loci: allele distributions in different populations. Ann Hum Genet 1996;60:391-400.
19. Thacker J, Chalk J, Ganesh A, North P. A mechanism for deletion formation in DNA by human cell extracts: the involvement of short sequence repeats. Nucleic Acids Res 1992;20:6183-8.
20. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure. (The international collaborative POF in Fragile X study.) Am J Med Genet 1999;83:322-5.